Experience with high‐risk human papillomavirus testing on vaginal brush‐based self‐samples of non‐attendees of the cervical screening program
Open Access
- 11 April 2011
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 130 (5) , 1128-1135
Abstract
We evaluated the effect of offering brush‐based vaginal self‐sampling for high‐risk human papillomavirus (hrHPV) testing to non‐attendees of the cervical screening program on response rate, compliance to follow‐up and cervical intraepithelial neoplasia grade 2 or 3 (CIN2+/CIN3+) yield. In addition, concordance of hrHPV test results between physician‐taken cervical scrapes and vaginal self‐samples was determined. A total of 26,409 nonattending women were randomly assigned to receive a vaginal brush device for hrHPV testing by Hybrid Capture‐2® method (i.e., self‐sampling group, n = 26,145) or a reinvitation for regular cytology‐based screening (i.e., recall control group, n = 264). hrHPV‐positive self‐sampling responders were invited for a physician‐taken scrape for cytology and blinded hrHPV testing. If cytology was abnormal, women were referred for colposcopy. Response rate in the self‐sampling group was significantly increased compared to the recall control group (30.8% versus 6.5%; p < 0.001). The concordance rate between hrHPV detection in self‐samples and corresponding physician‐taken cervical scrape samples was 68.8%. Amongst women with CIN3+ and CIN2+, the concordance rates in hrHPV positivity between both samples were 95.5% and 93.8%, respectively. Adherence at baseline to cytology triage of hrHPV‐positive self‐sampling women (89.1%) and colposcopy referral of those with abnormal cytology (95.8%) was high. The CIN2+/CIN3+/carcinoma yields were 1.5%, 1.0% and 0.1%, respectively, in self‐sampling responders. In conclusion, offering hrHPV testing on self‐sampled vaginal material with a brush device to non‐attendees significantly increases the attendance to the regular screening program, yields hrHPV test results that are in very good concordance with those of physician‐taken scrapes in women with CIN2+/CIN3+, and is effective in detecting CIN2+/CIN3+.Keywords
This publication has 17 references indexed in Scilit:
- Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self‐collected vaginal swabs of women who do not undergo cervical cytological screening in Southern FranceJournal of Medical Virology, 2010
- HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort studyBMJ, 2010
- Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population‐based cervical screening (VUSA‐screen study)International Journal of Cancer, 2009
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInternational Journal of Cancer, 2008
- Monitoring a national cancer prevention program: Successful changes in cervical cancer screening in the netherlandsInternational Journal of Cancer, 2006
- Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5+/6+ PCR Method in a Population-Based Cervical Screening ProgramJournal of Clinical Microbiology, 2006
- High Concordance of Results of Testing for Human Papillomavirus in Cervicovaginal Samples Collected by Two Methods, with Comparison of a Novel Self-Sampling Device to a Conventional Endocervical BrushJournal of Clinical Microbiology, 2006
- Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysisSexually Transmitted Infections, 2005
- Criteria for Organized Cervical Screening ProgramsActa Cytologica, 2002
- Missed Opportunities for Cervical Cancer Screening of HMO Members Developing Invasive Cervical Cancer (ICC)Gynecologic Oncology, 1998